-
Treatment Modalities for Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS): A Scoping Review of Prospective Treatment Studies
07 Apr 2025 09:01 GMT
… ). Neuromodulatory medications included centrally active medications (eg, antidepressants, anticonvulsants … trials of complementary/alternative treatments supported … + spironolactone, and sulindac on AIMSS symptoms were … study. J Nat Remedies. 2019;19:24 …
-
Piroxicam Drug Monograph
21 Jan 2025 19:35 GMT
… Pharmaceuticals. Diovan® … Clinoril® (sulindac) tablets prescribing … Drug Administration. FDA drug safety communication: FDA … drug in the database. The information contained in the database is not a substitute for medical care or treatment …
-
FDA Approved Drug Products Approval List November 2024
17 Dec 2024 07:53 GMT
Approval Date Drug Name Submission Active … 213112 SUPPL-12 TACROLIMUS CONCORD BIOTECH LTD Labeling Approval 11… 212608 SUPPL-20 AVAPRITINIB BLUEPRINT MEDICINES Labeling Approval 11/ … SULINDACANDA #072050 SUPPL-41 SULINDAC SUN PHARM INDUSTRIES Labeling …
-
Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification
24 Jun 2024 12:00 GMT
… address this significant unmet medical need. About Panbela … with the existing FDA-approved standard chemotherapy regimen … trial. Flynpovi ™
Flynpovi is a combination of CPP-1X (eflornithine) and sulindac … -initiated trials suggest that CPP-1X treatment may …
-
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
06 May 2024 12:00 GMT
… with the existing FDA-approved standard chemotherapy regimen … trial. Flynpovi ™
Flynpovi is a combination of CPP-1X (eflornithine) and sulindac … -initiated trials suggest that CPP-1X treatment may … patients with urgent unmet medical needs. Panbela’s …
-
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
22 Apr 2024 12:00 GMT
… with the existing FDA-approved standard chemotherapy regimen … trial comparing Flynpovi to single agent eflornithine and single agent sulindac … investigator-initiated trials suggest that CPP-1X treatment may … patients with urgent unmet medical needs. Panbela’s …
-
Identifying Risk Factors for Cardiovascular Events Among Active-Duty Service Members and Veterans Prescribed Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
15 Mar 2024 09:12 GMT
… drugs (NSAIDs) have been the cornerstone of treatment … meloxicam, naproxen, piroxicam, sulindac, and several others with low … of comorbidity profiles and medication adherence. The absence … randomized placebo-controlled NSAID trials. Aliment Pharmacol Ther. …
-
Panbela Exceeds 50% Enrollment for Aspire Trial in Pancreatic Cancer, Exceeding Anticipated Timelines with Accelerated Momentum
25 Jan 2024 12:00 GMT
… with the existing FDA-approved standard chemotherapy regimen … trial comparing Flynpovi to single agent eflornithine and single agent sulindac … investigator-initiated trials suggest that CPP-1X treatment may … patients with urgent unmet medical needs. Panbela’s …
-
Panbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modification
29 Nov 2023 13:15 GMT
… with the existing FDA-approved standard chemotherapy regimen … trial comparing Flynpovi to single agent eflornithine and single agent sulindac … investigator-initiated trials suggest that CPP-1X treatment may … patients with urgent unmet medical needs. Panbela’s …
-
Dental Caries: Practitioners' Perspective and Rationale for Using Aceclofenac and Paracetamol Combination Treatment in its Management
04 Sep 2023 08:22 GMT
… ketoprofen, flurbiprofen, indomethacin, sulindac, etodolac, mefenamic acid, … Paracetamol Combination Treatment
Combining NSAIDs with … of Biomedical and Pharmaceutical Sciences, 6(53 … Randomized Controlled Trial. Academic Emergency Medicine: Official Journal …
About
© 1995-2025